[1]
“Complementary-Therapy Use, Neuropathic Screening Status, and Quality of Life in Patients with Hypertension or Diabetes: A Pre–Post Observational Study”, JPS, vol. 9, no. 3, pp. 2688–2697, Aug. 2026, doi: 10.36490/journal-jps.com.v9i3.1836.